2013, Number 3
<< Back Next >>
Ann Hepatol 2013; 12 (3)
PGE2 induces MUC2 and MUC5AC expression in human intrahepatic biliary epithelial cells via EP4/p38MAPK activation
Li Y, Song J, Yu H, Wu S
Language: Spanish
References: 22
Page: 479-486
PDF size: 197.84 Kb.
ABSTRACT
Background. MUC2 and MUC5AC overproduction is considered to be associated with hepatolithiasis and related
to inflammation. However, mechanisms underlying MUC upregulation under inflammatory stimulation
in human intrahepatic biliary epithelial cells (HIBECs) are not completely understood.
Material and
Methods. Expression of MUC2 and MUC5AC mRNA in HIBECs was detected by real-time PCR. Expression of
COX-2, EP4, and phosphorylated ERK, JNK and p38MAPK protein was detected by Western blot. Concentrations
of PGE
2, IL-1β and TNF-α in cell culture supernatants were measured using the Quantikine Elisa kit.
Results. COX-2 expression as well as PGE
2 production in HIBECs was upregulated significantly by LPS, which
was completely blocked by either TLR4 antagonist or NFκB inhibitor. Selective COX-2 inhibitor suppressed
LPS-induced MUC2 and MUC5AC mRNA expression remarkably. Exogenous PGE2 increased MUC2 and MUC5AC
mRNA expression in a dosage-dependent manner independent of IL-1β and TNF-α. PGE2 receptor EP4 agonist
elevated MUC2 and MUC5AC expression, whereas EP4 antagonist had the opposite effect. Expression of
phosphorylated p38MAPK was upregulated by exogenous PGE
2, and p38MAPK inhibitor reduced MUC2 and
MUC5AC expression in HIBECs. In addition, it was found that levels of PGE
2, MUC2 and MUC5AC in bile samples
from the hepatic ducts affected by intrahepatic stones were significantly higher than those from the
unaffected hepatic ducts of patients with hepatolithiasis.
Conclusions. Our findings indicate that PGE
2 induces
MUC2 and MUC5AC expression in HIBECs via EP4-p38MAPK signaling.
REFERENCES
Johansson ME, Phillipson M, Petersson J, Velcich A, Holm L, Hansson GC. The inner of the two Muc2 mucin-dependent mucus layers in colon is devoid of bacteria. Proc Natl Acad Sci USA 2008; 105: 15064-9.
Van der Sluis M, De Koning BA, De Bruijn AC, Velcich A, Meijerink JP, Van Goudoever JB, Büller HA, et al. Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection. Gastroenterology 2006; 131: 117-29.
Bergstrom KS, Kissoon-Singh V, Gibson DL, Ma C, Montero M, Sham HP, Ryz N, et al. Muc2 protects against lethal infectious colitis by disassociating pathogenic and commensal bacteria from the colonic mucosa. PLoS Pathog 2010; 6: e1000902.
Takeyama K, Dabbagh K, Lee HM, Agustí C, Lausier JA, Ueki IF, Grattan KM, et al. Epidermal growth factor system regulates mucin production in airways. Proc Natl Acad Sci USA 1999; 96: 3081-6.
Fahy JV. Goblet cell and mucin gene abnormalities in asthma. Chest 2002; 122: 320S-326S.
Evans CM, Kim K, Tuvim MJ, Dickey BF. Mucus hypersecretion in asthma: causes and effects. Curr Opin Pulm Med 2009; 15: 4-11.
Vilkin A, Nudelman I, Morgenstern S, Geller A, Bar Dayan Y, Levi Z, Rodionov G, et al. Gallbladder inflammation is associated with increase in mucin expression and pigmented stone formation. Dig Dis Sci 2007; 52: 1613-20.
Sasaki M, Nakanuma Y, Kim YS. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepaticbiliary obstruction. Hepatology 1998; 27: 54-61.
Shoda J, Kano M, Asano T, Irimura T, Ueda T, Iwasaki R, Furukawa M, et al. Secretory low-molecular-weight phospholipases A2 and their specific receptor in bile ducts of patients with intrahepaticcalculi: factors of chronic proliferative cholangitis. Hepatology 1999; 29: 1026-36.
Shoda J, Ueda T, Kawamoto T, Todoroki T, Asano T, Sugimoto Y, Ichikawa A, et al. Prostaglandin E receptors in bile ducts of hepatolithiasis patients and the pathobiological significance for cholangitis. Clin Gastroenterol Hepatol 2003; 1: 285-96.
Zen Y, Harada K, Sasaki M, Tsuneyama K, Katayanagi K, Yamamoto Y, Nakanuma Y. Lipopolysaccharide induces overexpression of MUC2 and MUC5AC in cultured biliary epithelial cells: possible key phenomenon of hepatolithiasis. Am J Pathol 2002; 161: 1475-84.
Lee KT, Sheen PC. Proliferating cell nuclear antigen expression in peribiliary glands of stone-containing intrahepatic bile ducts. Dig Dis Sci 1999; 44: 2251-6.
Li FY, Cheng NS, Mao H, Jiang LS, Cheng JQ, Li QS, Munireddy S. Significance of controlling chronic proliferative cholangitis in the treatment of hepatolithiasis. World J Surg 2009; 33: 2155-60.
Li FY, Cheng NS, Cheng JQ, Mao H, Jiang LS, Li QS, Zhou Y. Practical value of applying cdc2 kinase shRNA to chronic proliferative cholangitis in treatment ofhepatolithiasis. Hepatogastroenterology 2009; 56: 1477-82.
Song KS, Lee WJ, Chung KC, Koo JS, Yang EJ, Choi JY, Yoon JH. Interleukin-1 beta and tumor necrosis factor-alpha induce MUC5AC overexpression through a mechanism involving ERK/p38 mitogen-activated protein kinases- MSK1-CREB activation in human airway epithelial cells. J Biol Chem 2003; 278: 23243-50.
Gray T, Nettesheim P, Loftin C, Koo JS, Bonner J, Peddada S, Langenbach R. Interleukin-1beta-induced mucin production in human airway epithelium is mediated by cyclooxygenase-2, prostaglandin E2 receptors, and cyclic AMP-protein kinase A signaling. Mol Pharmacol 2004; 66: 337-46.
Lee J, Komatsu K, Lee BC, Lim JH, Jono H, Xu H, Kai H, et al. Phosphodiesterase 4B Mediates Extracellular Signal-regulated Kinase-dependent Up-regulation of Mucin MUC5AC Protein by Streptococcus pneumoniae by Inhibiting cAMPprotein Kinase A-dependent MKP-1 Phosphatase Pathway. J Biol Chem 2012; 287: 22799-811.
Finzi L, Barbu V, Burgel PR, Mergey M, Kirkwood KS, Wick EC, Scoazec JY, et al. MUC5AC, a gel-forming mucin accumulating in gallstone disease, is overproduced via an epidermal growth factor receptorpathway in the human gallbaldder. Am J Pathol 2006; 169: 2031-41.
Ikeda H, Sasaki M, Ohira S, Ishikawa A, Sato Y, Harada K, Zen Y, et al. Tumor necrosis factor-alpha induces the aberrant expression of mucus core protein-2 in nonneoplastic biliary epithelial cells via the upregulation of CDX2 in chronic cholangitis. Hepatol Res 2008; 38: 1006-17.
Ikeda H, Sasaki M, Ishikawa A, Sato Y, Harada K, Zen Y, Kazumori H, et al. Interaction of Toll-like receptors with bacterial components induces expression of CDX2 and MUC2 in rat biliary epithelium in vivo and in culture. Lab Invest 2007; 87: 559-71.
Legler DF, Bruckner M, Uetz-von Allmen E, Krause P. Prostaglandin E2 at new glance: novel insights in functional diversity offer therapeutic chances. Int J Biochem Cell Biol 2010; 42: 198-201.
Sugimoto Y, Narumiya S. Prostaglandin E receptors. J Biol Chem 2007; 282: 11613-7.